A prospective, randomized, double blind, double dummy, double blind, multinational , multicenter trial comparing the safety and efficacy of sequential moxifloxacin 400 once daily to piperacillin/tazobac followed by oral amoxillin/clavulanic acid tablets for the treatment of subjects with complicated skin ans skin structure infections